HSBC Holdings
AVXL icon

HSBC Holdings’s Anavex Life Sciences AVXL Stock Holding History

HSBC Holdings’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Buy
107,856
+79,072
+275% +$342K ﹤0.01% 2413
2025
Q4 		$104K Buy
+28,784
New +$176K ﹤0.01% 2786
2025
Q1 		– Sell
-10,347
Closed -$110K – 3040
2024
Q4 		$110K Buy
10,347
+302
+3% +$2.32K ﹤0.01% 2873
2024
Q3 		$56.5K Buy
+10,045
New +$58K ﹤0.01% 2872
2024
Q2 		– Sell
-10,407
Closed -$52.9K – 2941
2024
Q1 		$52.9K Buy
+10,407
New +$58.6K ﹤0.01% 2933

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

HSBC Holdings's AVXL Position: Q1 2026 in Review

HSBC Holdings increased its Anavex Life Sciences (AVXL) stake by 275% in Q1 2026, buying an estimated $342K and bringing the position to 107,856 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

HSBC Holdings first reported a position in AVXL in Q1 2024 and has held it in 5 quarters since. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • HSBC Holdings held 107,856 shares of Anavex Life Sciences worth $330K as of Q1 2026.
  • HSBC Holdings bought 79,072 Anavex Life Sciences shares in Q1 2026, an estimated $342K.
  • Anavex Life Sciences made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2413 holding.
  • HSBC Holdings first reported a position in Anavex Life Sciences in Q1 2024 and has held it in 5 quarters since.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.